-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Lexaria Bioscience Corp. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2024.
- Lexaria Bioscience Corp. Operating Income (Loss) for the quarter ending November 30, 2024 was -$2.69M, a 136% decline year-over-year.
- Lexaria Bioscience Corp. Operating Income (Loss) for the twelve months ending November 30, 2024 was -$7.3M, a 22.2% decline year-over-year.
- Lexaria Bioscience Corp. annual Operating Income (Loss) for 2024 was -$5.75M, a 12% increase from 2023.
- Lexaria Bioscience Corp. annual Operating Income (Loss) for 2023 was -$6.53M, a 1.28% increase from 2022.
- Lexaria Bioscience Corp. annual Operating Income (Loss) for 2022 was -$6.62M, a 16.4% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)